Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Amicus widens UPenn gene therapy collaboration
Biopharma Dive
Wed, 05/29/19 - 10:35 pm
Amicus Therapeutics
UPenn
gene therapy
Galafold
Fabry disease
How BioMarin May Revolutionize the Hemophilia Treatment Market
Motley Fool
Tue, 05/28/19 - 11:25 pm
Biomarin
gene therapy
hemophilia A
valrox
Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range
Yahoo/Reuters
Thu, 05/23/19 - 09:48 am
Novartis
Pharma CEOs
Vas Narasimhan
gene therapy
SMA
drug pricing
Zolgensma
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
Biopharma Dive
Wed, 05/22/19 - 09:06 pm
uniQure
gene therapy
Huntington's disease
clinical trials
AMT-130
David Hallal brings his first cell therapy company into the fold, and it's tied to a major league financing deal
Endpoints
Wed, 05/22/19 - 09:53 am
David Hallal
ElevateBio
cell therapy
gene therapy
AlloVir
Commentary: Novartis CEO: Gene therapy offers hope of cures in one treatment, but US needs new pricing and payment model
CNBC
Fri, 05/17/19 - 07:21 pm
gene therapy
cancer
Novartis
Pharma CEOs
Vas Narasimhan
GenSight’s Eye Disease Gene Therapy Shows Sustained Vision Improvement
BioSpace
Wed, 05/15/19 - 11:35 pm
Gensight Biologics
clinical trials
gene therapy
LHON
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups
Xconomy
Mon, 05/13/19 - 09:34 am
ElevateBio
gene therapy
cell therapy
Bluebird's not looking to break speed records with its first gene therapy launch
Fierce Pharma
Fri, 05/10/19 - 12:48 pm
Bluebird Bio
gene therapy
beta thalassemia
Zynteglo
drug launches
One of the world’s top experts in coronary heart disease is spearheading a new gene editing upstart out to transform the field
Endpoints
Tue, 05/7/19 - 06:54 pm
Verve Therapeutics
Sekar Kathiresan
gene therapy
Novartis makes final Zolgensma pitch before FDA decision
BioPharma Dive
Sun, 05/5/19 - 06:51 pm
Novartis
gene therapy
Zolgensma
FDA
spinal muscular atrophy
Highlights: American Society of Gene & Cell Therapy Meeting
BioSpace
Fri, 05/3/19 - 10:54 pm
gene therapy
cell therapy
Audentes Therapeutics
MaxCyte
Moderna Therapeutics
Translate Bio
Homology Medicines
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?
Xconomy
Thu, 05/2/19 - 11:00 am
gene therapy
SMA
spinal muscular atrophy
Novartis
Zolgensma
Novartis mulling $1.5 mln-$5 mln price range for SMA gene therapy
Yahoo/Reuters
Wed, 04/24/19 - 12:02 pm
Novartis
Zolgensma
gene therapy
drug pricing
spinal muscular atrophy
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
Xconomy
Sun, 04/21/19 - 12:16 am
FDA
CRISPR
gene therapy
Achaogen
Allergan
Alnylam
Adverum Biotechnologies
Blackstone Life Sciences
CBER Director Notes FY 2018 Accomplishments, Including Approval of Two Gene Therapies
BioSpace
Thu, 04/18/19 - 10:14 pm
FDA
CBER
gene therapy
St. Jude’s Gene Therapy Appears to Cure “Bubble Boy Disease”
BioSpace
Thu, 04/18/19 - 10:11 pm
gene therapy
SXCID
bubble boy syndrome
clinical trials
Ophthotech becomes Iveric in pivot to gene therapies
Fierce Biotech
Tue, 04/16/19 - 10:57 am
Ophthotech
Iveric Bio
gene therapy
Adverum Bio offers a late notification about FDA hold on lead gene therapy for wet AMD
Endpoints
Mon, 04/15/19 - 11:12 pm
Adverum Biotechnologies
CMC
gene therapy
wet age-related macular degeneration
FDA
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon
Xconomy
Mon, 04/15/19 - 10:07 am
gene therapy
M&A
Catalent
Paragon Bioservices
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »